CFDE Data Portal | Search KRT18P57

	Label	Description
	KRT18P57 associations Collection (Entity type)	Associations for KRT18P57_associations
	KRT18P57 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	KRT18P57 Gene (Entity type)	ENSG00000215867 - keratin 18 pseudogene 57
	GSE182680 GSE182683 dexamethasone 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE209698 calcitriol D 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

KRT18P57 associations

Associations for KRT18P57_associations

KRT18P57 associations.tsv

A file from IDG as part of the Harmonizome project

KRT18P57

ENSG00000215867 - keratin 18 pseudogene 57

GSE182680 GSE182683 dexamethasone 7 v 11 human up

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human up

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE113655 phenol 5 v 4 human dn

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 1 v 3 human dn

A Gene Set from LINCS

GSE209698 calcitriol D 2 v 1 human dn

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.